Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)

This trial is no longer accepting participants. For information / assistance in finding a clinical trial that is right for you, please contact Cancer AnswerLine: 800-865-1125.